Vai al contenuto principale della pagina

The $800 million pill : the truth behind the cost of new drugs / / Merrill Goozner



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Autore: Goozner Merrill <1950-> Visualizza persona
Titolo: The $800 million pill : the truth behind the cost of new drugs / / Merrill Goozner Visualizza cluster
Pubblicazione: Berkeley : , : University of California Press, , 2004
©2004
Descrizione fisica: 1 online resource (304 pages)
Disciplina: 338.4/3/61510973
Soggetto topico: Prescription pricing
Drugs - Prices
Pharmaceutical industry
Consumer education
Soggetto non controllato: american society
biochemists
biotech drugs
drug companies
drug cost
drug culture
drug funding
drug innovation
drug manufacturing
drug pricing
expose piece
genetic disorders
government funded research
high costs
human genome project
investments
medical breakthroughs
medical innovations
medical research
pharmaceutical companies
prescription drugs
private sector
public heath
public sector
research and development
us government
Note generali: Description based upon print version of record.
Nota di bibliografia: Includes bibliographical references and index.
Nota di contenuto: Front matter -- Contents -- Introduction -- PART ONE. BIOHYPE -- PART TWO. DIRECTED RESEARCH -- PART THREE. BIG PHARMA -- Notes -- Bibliography -- Acknowledgments -- Index
Sommario/riassunto: Why do life-saving prescription drugs cost so much? Drug companies insist that prices reflect the millions they invest in research and development. In this gripping exposé, Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying astronomically high prices for prescription drugs. Goozner demonstrates that almost all the important new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and at the National Institutes of Health. He reports that once the innovative work is over, the pharmaceutical industry often steps in to reap the profit. Goozner shows how drug innovation is driven by dedicated scientists intent on finding cures for diseases, not by pharmaceutical firms whose bottom line often takes precedence over the advance of medicine. A university biochemist who spent twenty years searching for a single blood protein that later became the best-selling biotech drug in the world, a government employee who discovered the causes for dozens of crippling genetic disorders, and the Department of Energy-funded research that made the Human Genome Project possible--these engrossing accounts illustrate how medical breakthroughs actually take place. The
Altri titoli varianti: Eight hundred million dollar pill
Titolo autorizzato: The  Visualizza cluster
ISBN: 1-282-35824-3
9786612358241
0-520-93928-X
1-59734-450-8
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910780445003321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui